CORT
Ticker
Corcept Therapeutics Incorporated
CORT · Healthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…Corcept Therapeutics Incorporated (CORT), in the Healthcare sector, has 47 disclosed filings on Paydirt over the trailing twelve months from 10 corporate insiders: 1 purchase and 46 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Nov 3 and filed Nov 5. The most active filer was William Guyer with 13 filings. Data as of Nov 7 2026.
Add to watchlistFilings, ttm
47
1 buy · 46 sells · 1 late
Traders, ttm
10
10 insiders
Volume, ttmiDollar value disclosed in the window
$94.8M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Nov 3
Filed Nov 4
ADViAverage daily dollar volume
$130.9M
market data
Share price · 12M
$72.77 (-3.6%)
Adjusted for splits and dividends.
Volume by month
Buys $3.3M
Sells $180.3M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
SMAll 11 filers
DMRecent filings
Sean MaduckSALE
Other
$2.0M25,000 sh across 3 lots
Exec Nov 2
Filed Nov 4 · 7:26 PM ET Roberto Wandenkolk VieiraSALE President, Oncology $674K
8,333 sh across 2 lots
Exec Nov 2
Filed Nov 4 · 7:20 PM ET James N WilsonSALE Director $1.1M
9,700 sh across 2 lots
Exec Oct 15
Filed Oct 16 · 6:24 PM ET Roberto Wandenkolk VieiraSALE President, Oncology $967K
8,333 sh across 3 lots
Exec Oct 2
Filed Oct 5 · 7:58 PM ET Joseph Douglas LyonSALE See Remarks $1.1M
9,190 sh across 2 lots
Exec Oct 2
Filed Oct 5 · 7:54 PM ET Sean MaduckSALE See Remarks $2.9M
24,587 sh across 2 lots
Exec Oct 2
Filed Oct 5 · 7:49 PM ET Sean MaduckSALE See Remarks $2.9M
25,000 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 9:16 PM ET Roberto Wandenkolk VieiraSALE President, Oncology $6.5M
58,333 sh across 7 lots
Exec Sep 2
Filed Sep 3 · 9:02 PM ET Sean MaduckSALE See Remarks $3.9M
30,955 sh across 2 lots
Exec Aug 25
Filed Aug 27 · 4:30 PM ET David L MahoneySALE Director $12.2M
103,206 sh across 3 lots
Exec Aug 18
Filed Aug 20 · 4:30 PM ET Sean MaduckSALE See Remarks $419K
3,664 sh × $114.49
Exec Aug 14
Filed Aug 18 · 4:30 PM ET James N WilsonSALE Director $1.1M
10,000 sh across 3 lots
Exec Aug 14
Filed Aug 18 · 4:30 PM ET Gary Charles RobbSALE Chief Business Officer $1.2M
10,000 sh × $116.26
Exec Aug 17
Filed Aug 18 · 4:30 PM ET Sean MaduckSALE See Remarks $118K
1,031 sh × $114.52
Exec Aug 10
Filed Aug 12 · 4:27 PM ET William GuyerSALE Chief Development Officer $1.8M
16,300 sh across 2 lots
Exec Aug 10
Filed Aug 12 · 4:26 PM ET William GuyerSALE Chief Development Officer $419K
3,700 sh × $113.12
Exec Aug 4
Filed Aug 6 · 6:44 PM ET Sean MaduckSALE See Remarks $2.3M
20,305 sh × $114.70
Exec Aug 3
Filed Aug 5 · 5:51 PM ET Joseph Douglas LyonSALE See Remarks $176K
1,540 sh × $114.16
Exec Aug 3
Filed Aug 5 · 5:48 PM ET Atabak MokariSALE Chief Financial Officer $9.1M
79,000 sh across 11 lots
Exec Jul 30
Filed Aug 3 · 4:30 PM ET James N WilsonSALE Director $789K
8,921 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 6:38 PM ET Atabak MokariSALE Chief Financial Officer $3.5M
39,899 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 6:31 PM ET William GuyerSALE Chief Development Officer $1.8M
19,048 sh × $93.11
Exec Jul 7
Filed Jul 8 · 7:54 PM ET Sean MaduckSALE See Remarks $2.2M
25,000 sh across 3 lots
Exec Jul 1
Filed Jul 6 · 4:44 PM ET David L MahoneySALE Director $1.7M
20,000 sh × $84.53
Exec Jun 17
Filed Jun 18 · 5:30 PM ET James N WilsonSALE Director $832K
10,000 sh across 2 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET